This site is intended for Healthcare Professionals only.

Search results for: financial strain

Gilead prices Covid-19 drug Remdesivir at £1,904 per patient  

Gilead Sciences Inc on Monday (June 29) priced its Covid-19 antiviral remdesivir at $2,340 (£1,904) per patient for wealthier nations and agreed to send...

BREAKING: PSNC secures ‘another stop-gap measure’ as community pharmacy gets £50m more of advance funding to alleviate cashflow issues

The Pharmaceutical Services Negotiating Committe (PSNC) has secured a further £50 million of advance funding into community pharmacies at the end of May. According PSNC, the...

International pharmacy body issues urgent ‘call to action’ to support frontline pharmacy teams

The International Pharmaceutical Federation (FIP) has issued call to action to governments to support frontline pharmacy teams. On Tuesday (April 14), it asked governments and...

Two new community pharmacy services on the anvil to fight COVID-19

The government is planning to commission two new services from the community pharmacy sector to fight the COVID-19 pandemic, PSNC revealed yesterday (19 March) NHS...

NHS to suspend ‘certain requirements’ on pharmacies with income protection

NHS England said it will temporarily suspend certain requirements on community pharmacists with a guarantee to protect income. In a letter dated 17 March, Simon...

Increase in prescription charge deeply concerning: RPS; pharmacist tweets £9.00 was ‘easy’

The Royal Pharmaceutical Society on Tuesday expressed concern over the latest increase in prescription charges. Following the announcement of a 15p increase from April 1,...